Autotransfusion Devices Market

The global market value of the autotransfusion devices market was estimated to be USD 309.7 million in 2024 and is projected to grow at a CAGR of 6.7% during the forecast period. Autotransfusion is a process that makes a patient capable of using his/her own blood instead of depending upon donated blood during the surgeries. Organ transplants often witness significant blood loss during the process, and the role of autotransfusion devices during this process becomes very crucial. The increasing number of surgeries worldwide is driving the demand for the autotransfusion devices market.

Increasing global population is resulting in a higher number of people suffering from chronic diseases like cancer, diabetes, and cardiovascular diseases, and a higher number of surgeries occurring. The increasing number of surgeries worldwide is driving the demand for autotransfusion devices in the market significantly. A growing geriatric population and increasing demand for advanced blood management systems are driving the growth in the market.

Growth Drivers

Increasing growth in surgical interventions globally, particularly in cardiovascular and orthopedic fields, is driving growth in the market significantly. Drastically increasing cardiovascular conditions among the patients, especially after the pandemic, is a key factor behind the growth in the market. Next-generation intelligent control software has enhanced the efficiency and safety of autotransfusion procedures. Increasing emphasis on reducing transfusion-related complications is driving the demand in the market. The proliferation of ambulatory surgical centers, well-known for their cost-effectiveness and efficiency, is increasing the adoption of autotransfusion devices.

Increasing demand for minimally invasive procedures is the key reason behind the ASCs going for autotransfusion devices. ASCs provide skilled surgeons, advanced medical equipment, and a lesser risk of infection than hospitals. Furthermore, autotransfusion systems play a crucial role in managing intraoperative blood loss and promoting hemostasis during complex surgical procedures, thereby enhancing surgical outcomes and aiding in patient recovery.

Segmentation

Autotransfusion Devices Market, by Type

·         Autotransfusion Products

o   Intraoperative Autotransfusion Systems

o   Postoperative Autotransfusion Systems

o   Dual-Mode Autotransfusion Systems

·         Autotransfusion Accessories

Autotransfusion Devices Market, by Application

·         Cardiac Surgeries

·         Orthopedic Surgeries

·         Organ Transplantation

·         Trauma Procedures

·         Other Procedures (Obstetrics & Gynecological, Neurological, and Urological Procedures)

By Region

·         Asia-Pacific

·         North America

·         Latin America

·         Middle East and Africa

·         Europe

Autotransfusion Devices Market by Type

On the basis of the type, the autotransfusion devices market is segmented into auto-transfusion products, and accessories. Autotransfusion products are the leading segment in the market significantly. its role is vital in collection, processing, and reinfusion of blood. These products are expensive and account for the major share of the market revenue compared to accessories, which are lower-cost consumables. Increasing demand for investment by the manufacturers in research and development to improve autotransfusion products with better automation, and compact design.

Hospitals and clinics tend to focus more on the system itself when making the procurement decisions, considering systems capabilities, and brand reputation. Moreover, the increasing adoption of autotransfusion systems across a wide range of surgical specialties, including cardiac surgery, orthopedics, trauma surgery, and transplant procedures, has further propelled the growth of this segment.

Autotransfusion Devices Market by Application

On the basis of the application, the autotransfusion devices market is segmented into cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, and other procedures (obstetrics & gynecological, neurological, and urological procedures). Cardiac surgeries are the leading market segment due to the increasingly growing number of cardiac patients and substantial blood loss during the cardiac procedures. Autotransfusion devices reduce the risk of infection due to allogeneic blood transfusions. Rising prevalence of cardiac disorders worldwide due to lifestyle imbalance is spurring the growth in the market.

Orthopedic procedures, such as joint replacement and spinal surgeries, involve considerable blood loss. Autotransfusion devices are important because of collecting this blood efficiently and reducing reliance on donated blood. It reduces the chance of infection. Geriatric people are more injury-prone, and they are contributing significantly to the orthopedic surgery segment. The increasing number of sports-related injuries is also driving the demand in the market significantly. Organ transplantation procedures are associated with a significant amount of blood loss; they require an essential blood management strategy, and thus autotransfusion devices play a crucial role by enabling the patient’s own blood and reducing the risk of infection. With advancements in surgical techniques and a global increase in organ transplant surgeries, especially liver and kidney transplants, autotransfusion devices are witnessing significant demand.

Regional Outlook

On the basis of the regions, the autotransfusion devices market is segmented into 5 regions: Asia-Pacific, North America, Latin America, the Middle East and Africa, and Europe. North America is the leading region in the market and is expected to dominate the market during the forecast period due to the increasing number of cardiac patients and rapid enhancement in the number of cardiac and orthopedic surgeries. The presence of key players like Haemonetics Corporation, Becton, Dickinson and Company, LivaNova, and Medtronic is fueling the market growth in the region significantly.

Rising prevalence of cardiovascular diseases and rising healthcare expenditure are the reasons behind the market growth in the Asia-Pacific region. Increasing populations in emerging economies like China, India, and South Korea are witnessing rapid growth in the number of cardiac patients. Increasing demand for surgeries in the region is the key factor behind the significant growth in the market.

The European market is also witnessing significant growth due to the rapidly growing geriatric population, which is more disease-prone, and the increasing number of patients with cardiac and orthopedic conditions is driving the market towards success. Strong emphasis on intraoperative and postoperative cell salvage techniques is the reason behind the growth in the market.

Germany, the United Kingdom, France, and Italy are the key contributors in the market. Advancement in medical technologies in these countries is driving the growth in the market. Growing emphasis on patient safety and efficient blood management practices is driving the demand for autotransfusion devices in the market. Presence of major market players are significantly contributing to market growth.

Key Players

·         Medtronic Plc

·         Becton, Dickinson and Company

·         Zimmer Biomet Holdings Inc.

·         Teleflex Incorporated

·         LivaNova

·         Fresenius

·         Atrium Medical Corporation

·         Haemonetics Corporation

·         SARSTEDT

·         Braile Biomédica

·         Redax

·         Beijing ZKSK Technology Co

·         Gen World Medical Devices

·         Other Players